Startseite Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor

Veröffentlicht/Copyright: 31. Oktober 2007
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 45 Heft 11

Abstract

Background: Decreased concentrations of the circulating angiogenic factors, free placental growth factor (PLGF) and free vascular endothelial growth factor (VEGF), and increased concentrations of the anti-angiogenic factor, soluble fms-like tyrosine kinase 1 (sFLT-1) have been observed during clinical preeclampsia. We established a new PLGF-ELISA kit for the measurement of PLGF in sera. In the present study, we demonstrated the assay characteristics by measurement of PLGF expression in normal and preeclamptic pregnancies as compared to an established research kit.

Methods: Blood samples were taken from 64 women with singleton uncomplicated pregnancies for longitudinal measurement of PLGF in the course of pregnancy. In 30 preeclamptic patients, serum levels of PLGF and sFLT-1 were measured by Human PLGF-ELISA and Human sVEGF R1 ELISA according to the described test principles. The assay characteristics of the new PLGF-ELISA were determined and the results were compared to those performed with an available research kit.

Results: The PLGF concentration in normal pregnancies showed a steady increase starting at the beginning of the second trimester with a peak at 28–32 weeks and a consistent decline thereafter. The preeclamptic pregnancies had significant lower serum concentrations of PLGF and significant higher serum concentrations of sFLT-1 as compared to the non-preeclamptic pregnancies. All the measured assay characteristics fulfilled the required specifications. Comparison of the values of the new PLGF-ELISA and the established research kit resulted in a correlation coefficient of 0.921.

Conclusions: Our results support the hypothesis that an imbalance between factors promoting angiogenesis, such as PLGF, and factors antagonizing angiogenesis, such as sFLT-1, has a fundamental role in the pathogenesis of preeclampsia. The new established ELISA test can be considered reliable and it offers many advantages. As it is authorized for routine diagnostic testing, it may offer new possibilities in the prediction of preeclampsia in clinical routine.

Clin Chem Lab Med 2007;45:1504–10.


Corresponding author: Dr. Markus Schmidt, MD, Department of Gynecology and Obstetrics, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany Phone: +49-201-723-85290, Fax: +49-201-723-5962

Received: 2007-5-15
Accepted: 2007-7-23
Published Online: 2007-10-31
Published in Print: 2007-11-01

©2007 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Current state and future directions of neurochemical biomarkers for Alzheimer's disease
  2. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations
  3. Analysis of ferritin genes in Parkinson disease
  4. Multimers and adiponectin gene 276G>T polymorphism in the Japanese population residing in rural areas
  5. Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp.
  6. A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease
  7. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian patients
  8. How useful are housekeeping genes? Variable expression in melanoma metastases
  9. Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy
  10. Isobutyryl-CoA dehydrogenase deficiency with a novel ACAD8 gene mutation detected by tandem mass spectrometry newborn screening
  11. Circulating levels of osteoprotegerin and receptor activator of NF-κB ligand in patients with chronic renal failure
  12. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor
  13. Impact of rosiglitazone on the expression of β3-AR in the stable cell lines expressed β3-AR gene
  14. Biochemical and hormonal composition, cytological examination of thyroid cyst fluid, and comparison according to gender and color of cyst fluid
  15. Redefining functional sensitivity of thyroglobulin assay on Immulite platform: implications in thyroid cancer management
  16. Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age
  17. Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis
  18. Point-of-care creatinine testing in children at risk for sudden deterioration of renal function
  19. Utility of PFA-100® closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro
  20. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit
  21. Validation study of Axis-Shield carbohydrate-deficient transferrin (CDT) on ARCHITECT® chemistry analyzer
  22. High free serum acrolein levels in bacterial infection and other disease states associated with oxidative stress: a potential biomarker?
  23. Increased serum S100B protein in chronic schizophrenic patients in Korea
  24. Addendum to the recent report of EC4 on the accreditation of medical laboratories in the European Union
  25. Reply to the letter written by Haeckel
  26. The systemic inflammatory response syndrome C-reactive protein and transthyretin conundrum
  27. Transthyretin, nutrition, and inflammation: response to Dr. Bernstein
  28. Erratum
Heruntergeladen am 26.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.316/html
Button zum nach oben scrollen